Biolife Sciences (Biolife Sciences) Gross Margin % : 19.80% (As of May. 2008)

Biolife Sciences Gross Margin % Chart

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
Gross Margin %	Get a 7-Day Free Trial										21.77	15.51	16.92	7.91	19.80

Competitive Comparison of Biolife Sciences's Gross Margin %

For the Medical Instruments & Supplies subindustry, Biolife Sciences's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biolife Sciences's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolife Sciences's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Biolife Sciences's Gross Margin % falls into.

Biolife Sciences Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Biolife Sciences's Gross Margin for the fiscal year that ended in Nov. 2007 is calculated as

Biolife Sciences's Gross Margin for the quarter that ended in May. 2008 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Biolife Sciences  (OTCPK:BLFE) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Biolife Sciences had a gross margin of 19.80% for the quarter that ended in May. 2008 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Biolife Sciences Gross Margin % Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description